These results collectively reveal that RRP15 expression is elevated in CRC and correlates with unfavorable clinicopathological characteristics and poor prognosis, which hints that RRP15 may contribute to CRC development and serve as a potential prognostic marker. This evidence concerns the gene RRP15 and colorectal carcinoma.